ORIGINAL RESEARCH article
Front. Immunol.
Sec. Viral Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1515741
This article is part of the Research TopicHerpesviruses: Pathogenesis and Host InteractionsView all 5 articles
Cytokine secretion patterns distinguish herpes simplex virus type 2 meningitis from herpes simplex virus type 2 genital herpes
Provisionally accepted
Moa Bjerhem Viklund1
Alexandra Svensson1,2
Marie Studahl1,2Petra Tunbäck1,2Eva-Marie Boman3Kenny Brandström4
Christine Lingblom1,2Azadeh Reyahi1Karolina Thörn1
Kristina Eriksson1,2*- 1University of Gothenburg, Gothenburg, Sweden
- 2Sahlgrenska University Hospital, Gothenburg, Sweden
- 3Södra Älvsborg Hospital, Borås, Västergötland, Sweden
- 4Skaraborg Hospital, Skövde, Sweden
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The aim of this study was to identify immune factors that distinguish patients with herpes simplex virus type 2 (HSV-2) meningitis from patients with HSV-2 genital herpes by analyzing demographic data, in vitro production of cytokines and other immune factors secreted by patient peripheral blood mononuclear cells (PBMC), and existing antibody responses. PBMC and plasma were collected from patients previously diagnosed with HSV-2 meningitis (n=49) and HSV-2 genital herpes (n=38). PBMC were cultured in the presence or absence of HSV-2 and followed by multiplex analyses of culture supernatants for a panel of immune factors including Th1 and inflammatory cytokines, interferons, and chemokines. Plasma was analyzed for type-specific HSV antibodies and HSV-2 DNA. The multivariate method OPLS-DA was used to identify immune response patterns that differentiate the two patient groups. The multivariate analysis showed that the immune profile differed significantly between the two different HSV-2 disease manifestations. Meningitis patients were distinguished by the spontaneous production of several anti-viral immune factors by PBMC including type I and type III IFNs. PBMC from HSV-2 meningitis patients also secreted significantly higher levels of IFN- in response to HSV-2 compared to PBMC from HSV-2 genital herpes patients.Blocking the type I IFN receptor reduced the production of HSV-2-induced IFN- by PBMC suggesting that enhanced production of type I IFNs could promote IFN- recall responses. The levels of HSV-2 type-specific antibodies did not differ between the patient groups. In conclusion, we show that HSV-2 meningitis leads to a more profound activation of both innate and acquired PBMC immune responses, compared to that of HSV-2 genital herpes. Whether these differences are the cause, or the consequence, of the different disease manifestations remains to be determined.
Keywords: HSV-2, Meningitis, genital herpes, Cytokines, multivariate analysis, Immune profile
Received: 23 Oct 2024; Accepted: 15 May 2025.
Copyright: © 2025 Bjerhem Viklund, Svensson, Studahl, Tunbäck, Boman, Brandström, Lingblom, Reyahi, Thörn and Eriksson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Kristina Eriksson, University of Gothenburg, Gothenburg, Sweden
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.